172 related articles for article (PubMed ID: 19479249)
1. Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI.
da Costa Mdo D; Spitz M; Bacheschi LA; Leite CC; Lucato LT; Barbosa ER
Neuroradiology; 2009 Oct; 51(10):627-33. PubMed ID: 19479249
[TBL] [Abstract][Full Text] [Related]
2. Wilson's disease: resolution of MRI lesions following long-term oral zinc therapy.
Huang CC; Chu NS
Acta Neurol Scand; 1996; 93(2-3):215-8. PubMed ID: 8741147
[TBL] [Abstract][Full Text] [Related]
3. Early neurological worsening in patients with Wilson's disease.
Litwin T; Dzieżyc K; Karliński M; Chabik G; Czepiel W; Członkowska A
J Neurol Sci; 2015 Aug; 355(1-2):162-7. PubMed ID: 26071888
[TBL] [Abstract][Full Text] [Related]
4. Correlation between neuroimaging, neurological phenotype, and functional outcomes in Wilson's disease.
Moura J; Pinto C; Freixo P; Alves H; Ramos C; Santos Silva E; Nery F; Gandara J; Lopes V; Ferreira S; Presa J; Ferreira JM; Miranda HP; Magalhães M
Neurol Sci; 2024 Jul; 45(7):3201-3208. PubMed ID: 38291197
[TBL] [Abstract][Full Text] [Related]
5. Clinical features, MRI brain, and MRS abnormalities of drug-naïve neurologic Wilson's disease.
Pulai S; Biswas A; Roy A; Guin DS; Pandit A; Gangopadhyay G; Ghorai PK; Sarkhel S; Senapati AK
Neurol India; 2014; 62(2):153-8. PubMed ID: 24823724
[TBL] [Abstract][Full Text] [Related]
6. Wilson's disease: magnetic resonance imaging (MRI) with clinical correlations in 16 cases.
Barbosa ER; Caramelli P; Bacheschi LA; Haddad MS; Magalhães AC; Menezes JR; Scaff M; Canelas HM
Rev Paul Med; 1993; 111(3):407-11. PubMed ID: 8108634
[TBL] [Abstract][Full Text] [Related]
7. A study of brain MRI characteristics and clinical features in 76 cases of Wilson's disease.
Zhong W; Huang Z; Tang X
J Clin Neurosci; 2019 Jan; 59():167-174. PubMed ID: 30385165
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation and treatment of Wilson's disease: a single-centre experience.
Pellecchia MT; Criscuolo C; Longo K; Campanella G; Filla A; Barone P
Eur Neurol; 2003; 50(1):48-52. PubMed ID: 12824712
[TBL] [Abstract][Full Text] [Related]
9. Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.
Starosta-Rubinstein S; Young AB; Kluin K; Hill G; Aisen AM; Gabrielsen T; Brewer GJ
Arch Neurol; 1987 Apr; 44(4):365-70. PubMed ID: 3827691
[TBL] [Abstract][Full Text] [Related]
10. Subclinical neurological involvement does not develop if Wilson's disease is treated early.
Dubbioso R; Ranucci G; Esposito M; Di Dato F; Topa A; Quarantelli M; Matarazzo M; Santoro L; Manganelli F; Iorio R
Parkinsonism Relat Disord; 2016 Mar; 24():15-9. PubMed ID: 26851839
[TBL] [Abstract][Full Text] [Related]
11. Wilson's disease: MRI with clinical correlation.
Magalhaes AC; Caramelli P; Menezes JR; Lo LS; Bacheschi LA; Barbosa ER; Rosemberg LA; Magalhaes A
Neuroradiology; 1994; 36(2):97-100. PubMed ID: 8183467
[TBL] [Abstract][Full Text] [Related]
12. Cranial MRI in Wilson's disease.
Prayer L; Wimberger D; Kramer J; Grimm G; Oder W; Imhof H
Neuroradiology; 1990; 32(3):211-4. PubMed ID: 2215906
[TBL] [Abstract][Full Text] [Related]
13. Kayser-Fleischer ring in Wilson's disease: a cohort study.
Fenu M; Liggi M; Demelia E; Sorbello O; Civolani A; Demelia L
Eur J Intern Med; 2012 Sep; 23(6):e150-6. PubMed ID: 22863441
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
Schumacher G; Platz KP; Mueller AR; Neuhaus R; Steinmüller T; Bechstein WO; Becker M; Luck W; Schuelke M; Neuhaus P
Clin Transplant; 1997 Jun; 11(3):217-24. PubMed ID: 9193846
[TBL] [Abstract][Full Text] [Related]
15. Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease.
Zhang J; Xiao L; Yang W
BMC Neurol; 2020 Jun; 20(1):255. PubMed ID: 32593295
[TBL] [Abstract][Full Text] [Related]
16. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of neurological Wilson's disease with corpus callosum abnormalities.
Zhou ZH; Wu YF; Cao J; Hu JY; Han YZ; Hong MF; Wang GQ; Liu SH; Wang XM
BMC Neurol; 2019 May; 19(1):85. PubMed ID: 31053106
[TBL] [Abstract][Full Text] [Related]
18. Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson's disease patients with penicillamine-induced allergy or early neurological deterioration.
Zhu XQ; Li LY; Yang WM; Wang Y
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32809015
[TBL] [Abstract][Full Text] [Related]
19. Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.
Huang CC; Chu NS
Eur Neurol; 1998; 39(1):32-7. PubMed ID: 9476721
[TBL] [Abstract][Full Text] [Related]
20. The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging.
Zhou XX; Li XH; Chen DB; Wu C; Feng L; Chu JP; Yang ZY; Li XB; Qin H; Li GD; Huang HW; Liang YY; Liang XL
Brain Behav; 2018 May; 8(5):e00930. PubMed ID: 29761003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
